Back

ASCO Plenary Dec 2022 - ASCO Plenary Series: December 2022

Dec 20 - Dec 20, 2022 | AlexandriaVAUS

LARVOL is not affiliated with ASCO Plenary Series: December 2022 and all trademarks, logos, and brand names are property of their respective owners

Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID

Showing 1 titles linked to Trials

ARC-7: Randomized phase 2 study of domvanalimab + zimberelimab ± etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC).

10 Twitter Reactions